Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 111

Similar articles for PubMed (Select 24349535)

1.

Improved mitochondrial function underlies the protective effect of pirfenidone against tubulointerstitial fibrosis in 5/6 nephrectomized rats.

Chen JF, Liu H, Ni HF, Lv LL, Zhang MH, Zhang AH, Tang RN, Chen PS, Liu BC.

PLoS One. 2013 Dec 9;8(12):e83593. doi: 10.1371/journal.pone.0083593. eCollection 2013.

2.

Pirfenidone inhibits macrophage infiltration in 5/6 nephrectomized rats.

Chen JF, Ni HF, Pan MM, Liu H, Xu M, Zhang MH, Liu BC.

Am J Physiol Renal Physiol. 2013 Mar 15;304(6):F676-85. doi: 10.1152/ajprenal.00507.2012. Epub 2012 Nov 14.

3.

Renoprotective properties of pirfenidone in subtotally nephrectomized rats.

Takakuta K, Fujimori A, Chikanishi T, Tanokura A, Iwatsuki Y, Yamamoto M, Nakajima H, Okada M, Itoh H.

Eur J Pharmacol. 2010 Mar 10;629(1-3):118-24. doi: 10.1016/j.ejphar.2009.12.011. Epub 2009 Dec 13.

PMID:
20006961
4.

Antifibrotic effects of pirfenidone in rat proximal tubular epithelial cells.

Takakura K, Tahara A, Sanagi M, Itoh H, Tomura Y.

Ren Fail. 2012;34(10):1309-16. doi: 10.3109/0886022X.2012.718955. Epub 2012 Sep 24. Erratum in: Ren Fail: 2012;34(10):1316.

PMID:
23002925
5.

Novel cardiolipin therapeutic protects endothelial mitochondria during renal ischemia and mitigates microvascular rarefaction, inflammation, and fibrosis.

Liu S, Soong Y, Seshan SV, Szeto HH.

Am J Physiol Renal Physiol. 2014 May 1;306(9):F970-80. doi: 10.1152/ajprenal.00697.2013. Epub 2014 Feb 19.

6.

Pirfenidone attenuates cardiac fibrosis in a mouse model of TAC-induced left ventricular remodeling by suppressing NLRP3 inflammasome formation.

Wang Y, Wu Y, Chen J, Zhao S, Li H.

Cardiology. 2013;126(1):1-11. doi: 10.1159/000351179. Epub 2013 Jul 2.

PMID:
23839341
7.

p-Cresyl sulfate causes renal tubular cell damage by inducing oxidative stress by activation of NADPH oxidase.

Watanabe H, Miyamoto Y, Honda D, Tanaka H, Wu Q, Endo M, Noguchi T, Kadowaki D, Ishima Y, Kotani S, Nakajima M, Kataoka K, Kim-Mitsuyama S, Tanaka M, Fukagawa M, Otagiri M, Maruyama T.

Kidney Int. 2013 Apr;83(4):582-92. doi: 10.1038/ki.2012.448. Epub 2013 Jan 16.

PMID:
23325087
8.

Modulation of mitochondrial glutathione status and cellular energetics in primary cultures of proximal tubular cells from remnant kidney of uninephrectomized rats.

Benipal B, Lash LH.

Biochem Pharmacol. 2013 May 1;85(9):1379-88. doi: 10.1016/j.bcp.2013.02.013. Epub 2013 Feb 16.

PMID:
23419872
9.

Differential effects of pirfenidone on acute pulmonary injury and ensuing fibrosis in the hamster model of amiodarone-induced pulmonary toxicity.

Card JW, Racz WJ, Brien JF, Margolin SB, Massey TE.

Toxicol Sci. 2003 Sep;75(1):169-80. Epub 2003 Jun 27.

10.

Fluorofenidone attenuates collagen I and transforming growth factor-beta1 expression through a nicotinamide adenine dinucleotide phosphate oxidase-dependent way in NRK-52E cells.

Peng ZZ, Hu GY, Shen H, Wang L, Ning WB, Xie YY, Wang NS, Li BX, Tang YT, Tao LJ.

Nephrology (Carlton). 2009 Sep;14(6):565-72. doi: 10.1111/j.1440-1797.2009.01129.x.

PMID:
19712256
11.

Mitochondrial superoxide plays a crucial role in the development of mitochondrial dysfunction during high glucose exposure in rat renal proximal tubular cells.

Munusamy S, MacMillan-Crow LA.

Free Radic Biol Med. 2009 Apr 15;46(8):1149-57. doi: 10.1016/j.freeradbiomed.2009.01.022. Epub 2009 Feb 3.

PMID:
19439219
12.

Reversal of cardiac and renal fibrosis by pirfenidone and spironolactone in streptozotocin-diabetic rats.

Miric G, Dallemagne C, Endre Z, Margolin S, Taylor SM, Brown L.

Br J Pharmacol. 2001 Jul;133(5):687-94.

13.

Effects of lecithinized superoxide dismutase and/or pirfenidone against bleomycin-induced pulmonary fibrosis.

Tanaka K, Azuma A, Miyazaki Y, Sato K, Mizushima T.

Chest. 2012 Oct;142(4):1011-9.

PMID:
22459774
14.

Ghrelin protects against renal damages induced by angiotensin-II via an antioxidative stress mechanism in mice.

Fujimura K, Wakino S, Minakuchi H, Hasegawa K, Hosoya K, Komatsu M, Kaneko Y, Shinozuka K, Washida N, Kanda T, Tokuyama H, Hayashi K, Itoh H.

PLoS One. 2014 Apr 18;9(4):e94373. doi: 10.1371/journal.pone.0094373. eCollection 2014.

15.

The mitochondria-targeted antioxidant mitoquinone protects against cold storage injury of renal tubular cells and rat kidneys.

Mitchell T, Rotaru D, Saba H, Smith RA, Murphy MP, MacMillan-Crow LA.

J Pharmacol Exp Ther. 2011 Mar;336(3):682-92. doi: 10.1124/jpet.110.176743. Epub 2010 Dec 15. Erratum in: J Pharmacol Exp Ther. 2012 Aug;342(2):596.

16.

Pirfenidone improves renal function and fibrosis in the post-obstructed kidney.

Shimizu T, Kuroda T, Hata S, Fukagawa M, Margolin SB, Kurokawa K.

Kidney Int. 1998 Jul;54(1):99-109.

17.

Renoprotective mechanisms of pirfenidone in hypertension-induced renal injury: through anti-fibrotic and anti-oxidative stress pathways.

Ji X, Naito Y, Weng H, Ma X, Endo K, Kito N, Yanagawa N, Yu Y, Li J, Iwai N.

Biomed Res. 2013;34(6):309-19.

18.
19.

Effects of pirfenidone on the generation of reactive oxygen species in vitro.

Giri SN, Leonard S, Shi X, Margolin SB, Vallyathan V.

J Environ Pathol Toxicol Oncol. 1999;18(3):169-77.

PMID:
15281229
20.

Indoxyl sulfate-induced activation of (pro)renin receptor is involved in expression of TGF-β1 and α-smooth muscle actin in proximal tubular cells.

Saito S, Shimizu H, Yisireyili M, Nishijima F, Enomoto A, Niwa T.

Endocrinology. 2014 May;155(5):1899-907. doi: 10.1210/en.2013-1937. Epub 2014 Mar 6.

PMID:
24601883
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk